previous compound ID: 523 next compound
InChIKey: DUHUCHOQIDJXAT-OLVMNOGESA-N
SMILES: CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "E Matthes" "GW Carlile" "J Goepp" "J Liao" "B Kus" "D Rotin" "R Robert" "DY Thomas" "SD Macknight"

chemical graph of compound 523





CID is 104845
synonyms found at PubChem are:
Alfaxalone, Alphaxalone, 23930-19-0, 5alpha-Pregnan-3alpha-ol-11,20-dione, alfaxolone, Alfaxalonum [INN-Latin], GR 2/234, Alfaxalona [INN-Spanish], 3alpha-Hydroxy-5alpha-pregnane-11,20-dione, UNII-BD07M97B2A, BRN 3217240, Alfadione, 3alpha-Hydroxy-5alpha-pregnan-11,20-dion, MLS000069684, MLS001076262, BD07M97B2A, CHEMBL190279, CHEBI:34531, 3-alpha-Hydroxy-5-alpha-pregnane-11,20-dione, (3-alpha,5-alpha)-3-Hydroxypregnane-11,20-dione, 3-Hydroxypregnane-11,20-dione, NCGC00023100-03, SMR000058494, DSSTox_CID_2576, DSSTox_RID_76638, Alphaxolone, DSSTox_GSID_22576, 5-alpha-Pregnane-11,20-dione, 3-alpha-hydroxy-, Alfaxalona, Alfaxalonum, (3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one, delta(16)-alfaxalone, SR-01000000168, Alfaxalone [INN:DCF:JAN], 5alpha-alphaxalone, Alfaxalone [INN:BAN:DCF:JAN], Alfaxalone (INN), CAS-23930-19-0, AC1L2XLT, Opera_ID_1629, Prestwick0_001002, Prestwick1_001002, Prestwick2_001002, Prestwick3_001002, D06UBH, 3 alpha-hydroxy-5 alpha-pregnane-11,20-dione, BIDD:PXR0037, Lopac0_000929, SCHEMBL57756, BSPBio_001123, 4-08-00-02091 (Beilstein Handbook Reference), SPBio_003004, BPBio1_001237, GTPL5461, DTXSID9022576, CTK8F7676, DUHUCHOQIDJXAT-OLVMNOGESA-N, MolPort-003-959-279, HMS1571I05, HMS2098I05, HMS2236N05, HMS3262J20, HMS3715I05, ZINC4081122, Tox21_110884, Tox21_500929, BDBM50164570, AKOS024457399, Tox21_110884_1, API0010033, CCG-205010, DB11371, LP00929, 5alpha-pregnane-3alpha-ol-11,20-dione, NCGC00023100-04, NCGC00023100-05, NCGC00023100-06, NCGC00023100-08, NCGC00261614-01, (3a,5a)-3-Hydroxypregnane-11,20-dione, LS-118546, (3?,5?)-3-Hydroxypregnane-11,20-dione, AB00384358, B7253, EU-0100929, C13803, D07282, P 5052, (3alpha,5alpha)-3-hydroxypregnane-11,20-dione, Pregnane-11,20-dione, 3-hydroxy-, (3a,5a)-, SR-01000076070, J-015280, SR-01000000168-2, SR-01000000168-3, SR-01000076070-1, BRD-K41445866-001-03-0, Pregnane-11,20-dione, 3-hydroxy-, (3-alpha,5-alpha)-, 5alpha-Pregnan-3alpha-ol-11,20-dione, powder, >=98% (TLC), Pregnane-11,20-dione, 3-hydroxy-, (3-alpha,5-alpha)- (9CI), (3R,5S,8S,9S,10S,13S,14S,17S)-17-Acetyl-3-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-11-one, EY4